https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Retinopathy prediction in type 2 diabetes: Time-varying Cox proportional hazards and machine learning models https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54491 Wed 28 Feb 2024 16:25:16 AEDT ]]> Do remittances reduce school dropout in Bangladesh? The role of government's administrative and structural support https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52352 Wed 13 Mar 2024 07:45:08 AEDT ]]> Evaluation of transitions from early hypertension to hypertensive chronic kidney disease, coronary artery disease, stroke and mortality: a Thai real-world data cohort https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52406 Wed 11 Oct 2023 11:51:59 AEDT ]]> Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13693 Wed 11 Apr 2018 14:32:54 AEST ]]> Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30808 Wed 11 Apr 2018 12:31:21 AEST ]]> Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48061 Tue 21 Feb 2023 12:10:04 AEDT ]]> Charlson Comorbidity Index as a predictor of repeated hospital admission and mortality among older women diagnosed with cardiovascular disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42868 Tue 06 Sep 2022 09:52:29 AEST ]]> Hemodynamic response to exercise for prediction of development of kidney failure revealing a cardiorenal secret cross talk https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30003 Thu 13 Jan 2022 10:28:39 AEDT ]]> Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25708 Sat 24 Mar 2018 07:28:18 AEDT ]]> Using a counting process method to impute censored follow-up time data https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32029 Mon 23 Sep 2019 13:08:25 AEST ]]> Deep Bayesian survival analysis of rail useful lifetime https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53190 Fri 17 Nov 2023 12:01:30 AEDT ]]> Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43389 15 years at three hospitals: Alice Springs Hospital and Monash Medical Centre in Australia, and Middlemore Hospital in New Zealand. Data included demographics, ethnicity, sputum microbiology, radiology, spirometry, hospitalization and survival over 5 years of follow-up. Results: Aboriginal Australians were significantly younger and died at a significantly younger age than other groups. Age- and sex-adjusted all-cause mortality was higher for Aboriginal Australians (hazard ratio (HR): 3.9), and respiratory-related mortality was higher for both Aboriginal Australians (HR: 4.3) and Māori and Pacific Islander people (HR: 1.7). Hospitalization was common: Aboriginal Australians had 2.9 admissions/person-year and 16.9 days in hospital/person-year. Despite Aboriginal Australians having poorer prognosis, calculation of the FACED score suggested milder disease in this group. Sputum microbiology varied with Aspergillus fumigatus more often isolated from non-indigenous patients. Airflow obstruction was common (66.9%) but not invariable. Conclusions: Bronchiectasis is not one disease. It has a significant impact on healthcare utilization and survival. Differences between populations are likely to relate to differing aetiologies and understanding the drivers of bronchiectasis in disadvantaged populations will be key.]]> Fri 16 Sep 2022 09:37:47 AEST ]]>